All posts tagged "Merck"
-
Merck Works To Treat Patients With ‘Molecules’
With 500+ Workers, 10 Clinical Studies in P.R., Pharma Targets Cancer, Dengue, Ebola, HIV, Improving Lives of Diabetes Patients
- Posted November 19, 2018
-
Startup raises nearly $9 million to commercialize lab-grown meat
Merck backing could accelerate product's market arrival
- Posted July 17, 2018
-
Honor student participation at Animus Summit sponsored by Merck
Merck takes science undergrads to women's entrepreneurship conference
- Posted November 30, 2017
-
Trump mocks exec for quitting advisory council over racism
Merck CEO citing 'a responsibility to take a stand against intolerance and extremism'
- Posted August 14, 2017
-
Merck says new type of cholesterol drug worked in big study
Will consult experts before making it available in the market
- Posted June 27, 2017
-
Merck Receives ENERGY STAR Award From EPA
Las Piedras site in top 25 percent of pharmaceutical plant energy performance nationwide
- Posted April 1, 2016
-
Merck Beats 4Q Profit Forecast, Misses Street View on Sales
Merck & Co. posted an 87 percent drop in fourth-quarter profit compared with last year when the drugmaker had a huge gain from the sale of consumer health business. The strong dollar and increasing competition for some...
- Posted February 3, 2016
-
FDA OKs Merck Hepatitis C Drug, Adding to Patient Choices
TRENTON, N.J. – Patients with hepatitis C have yet another advanced treatment option, as the Food and Drug Administration on Thursday approved a new once-a-day pill developed by drugmaker Merck. The FDA said Merck can begin marketing...
- Posted January 28, 2016
-
Merck Pays $830M to Settle Class-action Case over Vioxx
Merck will pay $830 million to resolve a federal class-action lawsuit involving shareholders and the painkiller Vioxx, which the drugmaker pulled from the market years ago over safety concerns. Merck said Friday that the case involved people...
- Posted January 15, 2016